Variable | potAVERT (n = 105) | AVERT (n = 50) | Effect size* (95%CI) | p | ||
---|---|---|---|---|---|---|
Stroke to needle (min) | ||||||
Median (IQR) | 138 | (108–156) | 126 | (108–156) | −1.2 (−15-13.2) | 0.88 |
NIHSS | ||||||
At 24 hours | ||||||
Median (IQR) | 5.5 | (2–12) | 8.5 | (5–14) | 2 (0–5) | 0.04 |
Physiological data at thrombolysis | ||||||
Hypertension | 31 | (62%) | 66 | (63%) | 0.96 (0.48-1.92) | >0.99 |
Hypotension | 0 | 0 | 1 | (2.0%) | N/A | 0.32 |
Hyperglycaemia | 3 | (3.3%) | 2 | (4.6%) | 1.41 (0–7.38) | 0.66 |
Hypoglycaemia | 0 | 0 | 2 | (4.6%) | N/A | 0.10 |
Bradycardia | 13 | (12%) | 10 | (20%) | 1.77 (0.73-4.30) | 0.23 |
Tachycardia | 9 | (8.6%) | 4 | (8.0%) | 0.93 (0.29-3.01) | >0.99 |
Arythmia | 24 | (25%) | 15 | (33%) | 1.48 (0.69-3.18) | 0.32 |
Rapid atrial fibrillation | 5 | (4.9%) | 3 | (6.0%) | 1.24 (0.31-4.92) | 0.72 |
Hypoxia | 1 | (1.0%) | 0 | 0 | N/A | >0.99 |
Complications at 24 h post thrombolysis | ||||||
Hemorrhagic transformation | 14 | (13%) | 10 | (20%) | 1.63 (0.68-3.91) | 0.34 |
sICH | 0 | 0 | 1 | (2.0%) | N/A | 0.32 |
Bleeding other than cerebral | 12 | (11%) | 3 | (6.0%) | 0.49 (0.14-1.7) | 0.39 |
DVT | 1 | (1.0%) | 1 | (2.0%) | 2.12 (0) | 0.54 |
Infection | 9 | (8.6%) | 6 | (12%) | 1.45 (0.51-4.19) | 0.56 |